用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Handbook of Sepsis; W. Joost Wiersinga,Christopher W. Seymour Book 2018 Springer International Publishing AG, part of Springer Nature 2018

[复制链接]
楼主: monster
发表于 2025-3-27 00:44:09 | 显示全部楼层
发表于 2025-3-27 01:16:29 | 显示全部楼层
发表于 2025-3-27 07:11:30 | 显示全部楼层
发表于 2025-3-27 09:57:42 | 显示全部楼层
Sepsis Biomarkers also to provide an indication of severity and prognosis and of response to treatment. C-reactive protein and procalcitonin are the biomarkers that have been most widely studied in sepsis, but there are many other potential candidates, including CD64 expression, adrenomedullin, sTREM-1, and presepsi
发表于 2025-3-27 16:01:28 | 显示全部楼层
Fluids in Sepsisersial. While recent data have provided considerable insights, there remains uncertainty as to the type, rate and volume of fluid that should be administered. In addition, the appropriate balance between fluids and vasopressors to achieve adequate end-organ perfusion at various stages of the septic
发表于 2025-3-27 19:16:53 | 显示全部楼层
发表于 2025-3-27 23:14:53 | 显示全部楼层
发表于 2025-3-28 05:37:21 | 显示全部楼层
发表于 2025-3-28 06:24:01 | 显示全部楼层
Antimicrobial Therapyted to prognosis. Several studies have shown that inappropriate antimicrobial therapy was associated to increased mortality. An appropriate empiric antibiotic therapy includes, not only the susceptibility of the potential pathogen(s) to the agent(s), but also a correct timing for administration and
发表于 2025-3-28 12:23:55 | 显示全部楼层
Sepsis in Low- and Middle-Income Countriespite current epidemiological data suggesting a huge global burden of sepsis, knowledge regarding the incidence, prevalence, and mortality rates of sepsis is scarce, especially in low- and middle-income countries, which comprise 85% of the world’s population and usually have higher mortality rates th
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-1 06:40
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表